Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen for bleeding in contraceptive implant users
NCT02070692Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Feb 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen in abnormal uterine bleeding (AUB), sponsored by Oregon Health & Science University. Started Feb 2014; status: completed.
02
Drugs
tamoxifen
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT02070692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070692.